Articles Tagged With: Contraception
-
Is There a Link Between Hormonal Contraception and Depression?
Recent study results not as clear-cut as they seem -
LARC Options Expand With New Intrauterine Device
Family planning clinicians are adding another choice to the expanding list of long-acting reversible contraceptive options with the September 2016 FDA approval of the Kyleena 19.5 mg levonorgestrel IUD from Whippany, NJ-based Bayer HealthCare Pharmaceuticals. The new IUD is available as of October 2016 by prescription only.
-
FDA Approves IUS Contraceptive For Up to Five Years
The FDA approved Kyleena, a levonorgestrel-releasing, progestin-containing IUS, for up to five years.
-
Is an Even Safer Combined Oral Contraceptive Pill Available?
ABSTRACT & COMMENTARY: New study has many advantages, including ascertainment of important confounding variables.
-
Factor V Leiden Mutation and Combined Hormonal Contraception? Is Thrombosis Risk Acceptable?
A meta-analysis of cohort studies supports that women with mild thrombophilias like heterozygote Factor V Leiden mutation can use combined hormonal contraception if other reliable methods are not acceptable.
-
Still Highly Effective: LNG IUS 52 mg at 7 Years
Data from a large randomized study conducted by the World Health Organization demonstrate that pregnancy rates do not increase after year five, and support the continued use of the levonorgestrel intrauterine system 52 mg for contraception through seven years.
-
Infection Risk with Same-day Testing and IUD Insertion
In this prospective trial of same-day chlamydia/gonorrhea testing with intrauterine device insertion among 1,714 women, the risk of subsequent pelvic infection was extremely low (0.2%) over two years of follow-up.
-
Spend $5 and Save a Life
Spending less than $5 per person on healthcare services could save the lives of millions of mothers and children worldwide every year. -
Update on emergency contraception: What family planning providers need to know
Are you up to speed on emergency contraception? The Association of Reproductive Health Professionals has just released a two-part webinar to help providers review evidence-based information on all things EC, from its efficacy to the state of access in the United States.
-
Contraceptive selection for women with epilepsy
Epilepsy is common, affecting 2.2 million Americans, of which approximately half are women of reproductive age.1 The Association of Reproductive Health Professionals has just released a webinar, “Women with Nerve: Providing Reproductive Health Care for Women with Epilepsy,” to help providers review evidence-based information on the subject.